Pixium Vision SA PXMVF:OTCPK

RT Quote | Exchange | USD
Last | EDT
UNCH (UNCH)
52 week range
0.00 - 0.00

...

Loading . . .
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close-
  • 52 Week High0.00
  • 52 Week High Date-
  • 52 Week Low0.00
  • 52 Week Low Date-

Key Stats

  • Market Cap53.08M
  • Shares Out43.62M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close-
  • 52 Week High0.00
  • 52 Week High Date-
  • 52 Week Low0.00
  • 52 Week Low Date-
  • Market Cap53.08M
  • Shares Out43.62M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Pixium Vision SA

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Pixium Vision SA is a France-based company that specializes in sensory neuromodulation. The Company is focused on the development of implantable medical devices for the treatment of blindness caused by degeneration of photoreceptor cells in the retina. The Company develops two Vision Restoration Systems (VRS) platforms, including IRIS and PRIMA. The Company’s implant technology replaces the signal processing functions in the retina by electrically stimulating the retinal...
Bernard Gilly Ph.D.
Chairman
Lloyd Diamond
Chief Executive Officer
Didier Laurens
Chief Financial Officer
Guillaume Buc
Chief Technology Officer
Address
74 rue du Faubourg Saint-Antoine
Paris
75012
France